RICE CREEK MFG

Manufacturer adverse-event records for RICE CREEK MFG come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2002–2025 · thin-book · elevated Death-code · injury-heavy

Volume signature

RICE CREEK MFG is a thinner MAUDE footprint

RICE CREEK MFG accounts for 4,333 FDA MAUDE reports (#390 of 443, thin-book tercile). Death-coded event_type share is 2.26% (elevated); Injury share 51.9% (injury-heavy).

What the volume reading shows for RICE CREEK MFG

The standout signal for RICE CREEK MFG is filing volume: 4,333 adverse-event reports in FDA MAUDE (#390 of 443, thin-book). Death-coded event_type share sits at 2.26% (elevated).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Injury at 2,247 (51.9% of event_type total). Peak single-year volume reaches 1,762 reports across 23 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,333
Total Reports
98
Event-type Death
2,247
Injury Reports
20
Device Types

Event Types

Injury 2,247 (51.9%)
Malfunction 1,851 (42.7%)
Other 135 (3.1%)
Death 98 (2.3%)
2 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

1,646 (29.6%)
Hospitalization 1,279 (23.0%)
R 1,060 (19.0%)
Required Intervention 984 (17.7%)
Other 265 (4.8%)
L 121 (2.2%)
Death 96 (1.7%)
Life Threatening 57 (1.0%)
O 32 (0.6%)
S 14 (0.3%)
H 9 (0.2%)
Disability 5 (0.1%)
D 1 (0.0%)

Yearly Trend

02
2002: 15
03
2003: 152
04
2004: 107
05
2005: 51
06
2006: 156
07
2007: 163
08
2008: 148
09
2009: 60
10
2010: 84
11
2011: 58
12
2012: 419
13
2013: 1,762
14
2014: 249
15
2015: 230
16
2016: 142
17
2017: 109
18
2018: 98
19
2019: 109
20
2020: 206
21
2021: 7
22
2022: 1
24
2024: 2
25
2025: 5